New Guidelines Conclude All Aerosol Therapy Devices Equally Effective

Patient Education on Aerosol Therapy Key to Effective Asthma Control

<NorthBrook, Il., January 10, 2005> New evidence-based guidelines for the selection of aerosol medication devices conclude that health-care providers should avoid basing device selection exclusively on device efficacy. Instead, the choice should be based on other patient-related factors. All aerosolized medication delivery systems (SVN's, DPI's, MDI's with spacers) are equally effective when used properly.

For the first time, the American College of Chest Physicians (ACCP) and the American College of Allergy, Asthma, & Immunology (ACAAI) have developed joint evidenced-based guidelines for the selection of aerosol delivery devices. Published in the January issue of CHEST, the peer-reviewed journal of the ACCP, the guidelines were developed by an international panel of pulmonary experts.

"The current practice of device selection for the delivery of aerosolized asthma or COPD medication is largely based on the device's effectiveness in delivering the medication to the patient. Although there are advantages and disadvantages associated with each device and medication when used properly, all aerosol devices can work equally-well and can be interchanged," said guidelines chair Myrna B. Dolovich, P. Eng. Associate Clinical Professor Medicine & Radiology, McMaster University, Hamilton, Ontario, Canada. "Health-care providers should choose a device based on the individual characteristics of each patient. If asthma control is not achieved using one delivery device, it may be beneficial for patients to switch to another device after consulting with his or her provider."

Specific Recommendations include:

• Inpatient setting: Nebulizers and MDIs with spacers/holding chambers are appropriate for use in the inpatient setting.
• Emergency Department Setting: Nebulizers and MDIs with spacer/holding chambers are appropriate for the delivery of ß₂ -agonists in the emergency department.
• Patients supported by mechanical ventilation: Careful attention to details of the technique employed for administering medications by MDI or nebulizer to mechanically ventilated patients is critical, since multiple technical factors may have clinically important effects on the efficiency of aerosol delivery.

Overall, guidelines state that aerosolized medication delivery systems when used with comparable drug doses, provide equivalent efficacy and, therefore, recommend that health-care providers not base device selection exclusively on device efficacy but rather on several criteria, including; device availability, cost, convenience, patient's age, preference and competence in using the device.